Podcast Episodes
Back to Search
Episode 66: New Approach to Antithrombotics
Dr. Neil Hayward, CEO and founder of eXlthera, is here to discuss his company, which is developing Factor XI inhibitor antithrombotics that are attac…
5 years, 9 months ago
Episode 65: Creating a Path for Innovation
George Baxter, CEO of Edinburgh Innovations, is here to discuss the company's commercialization model, and how his group is bringing innovation to ma…
5 years, 9 months ago
Episode 64: The Complexities of Managing ADHD
Jack Khattar, president and CEO of Supernus Pharmaceuticals, talks about his experience bringing ADHD drugs to market in a challenging environment.
5 years, 10 months ago
Episode 63: Three Simple Principles to Improve Leadership
Eric Turbiville, author of the recently published book “The Perfect Leadership Triad: How Top Executives Maximize Productivity through People, Coachi…
5 years, 10 months ago
Episode 62: The Future of Pharma’s Supply Chain
Kurt Orlofski, CEO of Pharmaceutical Associates Inc., discusses what the pharmaceutical supply chain might look like post COVID-19, and how companies…
5 years, 11 months ago
Episode 61: Preparing for Virtual High-Stakes Meetings
Jim and Cindy DiBiasi, co-founders of 3D Communications, talk about how to prepare for virtual high-level meetings, such as important regulatory pres…
5 years, 11 months ago
Episode 60: Leading With Compassion
Tim Walbert, CEO of Horizon Therapeutics, shares his unique perspective on managing the Chicago location of the company through COVID-19, in light of…
6 years ago
Episode 59: Using Tau to Target Alzheimer’s
Janice Kranz, co-founder of Eikonizo Therapeutics, bring us up to date on how targeting tau to fight Alzheimer’s and other neurodegenerative diseases…
6 years ago
Episode 58: Understanding FDA’s Gene Therapy Guidelines
Dr. Jonathan Gertler, CEO of Back Bay Life Science Advisors, and Dr. Stephan Gauldie, Managing Director of Back Bay, talk about the new guidelines se…
6 years, 1 month ago
Episode 57: Planning for Pharma’s New Normal
Pratap Khedkar, managing principal of ZS Associates, talks about pharma’s scenario planning amid COVID-19 as it looks to settle into a new normal.
6 years, 1 month ago